Despite its worldwide distribution, the pathogenesis of Helicobacter pylori
associated gastroduodenal disease remains poorly understood. What is clear
is that H. pylori infection rarely resolves spontaneously and that the chr
onic gastritis that accompanies infection is typically maintained for the d
uration of infection. Ultimately, if untreated, this chronic inflammation p
redisposes a subset of individuals to develop gastric or duodenal ulcers an
d even gastric cancer. Chronic long-lasting H. pylori infection, particular
ly when acquired early in childhood, can predispose an individual to a sign
ificantly increased risk of developing gastric cancer. These studies were s
o compelling that the World Health Organization has recently classified H.
pylori as a type 1 human carcinogen. Since the discovery of H. pylori less
than 20 years ago, this infection has continued to generate considerable in
terest in the medical and scientific community. As we enter the new milleni
um, there are now a number of effective treatments for children in whom H,
pylori-associated peptic ulcer disease is diagnosed. Although there is now
overwhelming evidence to confirm that H. pylori plays an etiologic role in
the development of peptic ulcer disease, only a small number of these child
ren develop H. pylori disease. In this review, we highlight some of the rec
ently published pediatric studies addressing the role H. pylori plays in th
e development of gastroduodenal disease in children. (C) 2000 Lippincott Wi
lliams & Wilkins, Inc.